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Background: Gallbladder perforation is a serious complication of acute cholecystitis. Its management has
evolved considerably since its classiﬁcation by Niemeier in 1934. This review summarises the evidence
surrounding the natural progression of this condition and potential problems with Niemeier’s classiﬁ-
cation, and proposes a management algorithm for the more complex type II perforation.
Methods: Data from a retrospective case series and a systematic review were combined. The case series
included all patients with gallbladder perforations from 2004 to 2008 at a British teaching hospital. The
systematic review searched for gallbladder perforation using the MEDLINE, Embase, Web of Science and
Cochrane Library (2011 Issue 4) databases, as well as recent conference abstracts. The outcome data were
analysed using SPSS version 15. No adjustments were made for multiple testing.
Results: 198 patients (including 19 patients from the present series) with a mean age of 62.1þ/9.7
years and male gender proportion of 55.4% (range 33.3e76.7%) were included. The most common
gallbladder perforations were type II (median 46.2%, range 7.4e83.3%), followed by type I (median
40.6%, range 16.7e70.0%) and type III (median 10.1%, range 0e48.1%). Perforation was associated with
cholelithiasis in 86.6% (range 78.9e90.6%) of patients, and the overall median mortality rate was 10.8%
(range 0e12.5%). Male gender was weakly associated with mortality (p ¼ 0.089) but age (p ¼ 0.877) and
cholelithiasis (p ¼ 0.425) were not. Mortality did not vary signiﬁcantly with perforation type.
Conclusions: Gallbladder perforation should be reported according to the original Neimeier’s classiﬁca-
tion to avoid heterogeneity in data (e.g. varying rates of perforation types). The algorithm proposed
in this study aims to guide the management of complex type II gallbladder perforations to minimise
subsequent morbidity and mortality.
 2012 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Background
Gallbladder perforation is a rare but life-threatening complica-
tion of acute cholecystitis, with a reported mortality rate of
12e42%.1e3 In 1934, Niemeier classiﬁed the condition into threee following meetings-
hal. Evolving management of
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ciates Ltd. Published by Elsevier Lttypes: type I, acute perforation into the free peritoneal cavity; type
II, subacute perforation with abscess formation; and type III,
chronic perforation with ﬁstula formation between the gallbladder
and another viscus.4 Since the original classiﬁcation, diagnostic
modalities and therapeutic options have evolved considerably.
Papers describing variants of type III perforation,5,6 adapting novel
imaging techniques into the original Niemeier classiﬁcation,7 and
individual case series describing new treatment modalities,8 have
since been published.
Despite this, the aetiology of this condition remains poorly
understood and surgeons are often faced with diagnostic as well as
therapeutic challenges in managing such cases.
This study incorporates a single-institution experience of
managing this condition into a systematic review of the literature,
and proposes changes to the traditional classiﬁcation and manage-
ment algorithms for type II and III perforation to suit current surgical
practice.d. All rights reserved.
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Co-morbidities Day of deﬁnitive
therapy
Management
1 71 m AC I Meniere’s disease elective OC
2 53 m AC I HTN, CRD 2 OC
3 74 f AC I DM, HTN 6 OC
4 86 m Diverticulitis I Diverticular disease 2 OC
5 88 f Perforated duodenal
ulcer
I IHD, HTN, COPD 3 OC
6 56 m AC I Rectal cancer, ERCP þ stent 2 OC
7 54 m AC I e 11 OC
8 37 f AC I Vaginal ﬁstula 2 OC
9 74 f SBO I Rheumatoid arthritis 2 Cholecystostomy þ elective OC
10 83 m Cholangitis II DM, HTN, IHD, CRD 17 RD
11 65 m AC II DM, HTN, CRD 6 OC
12 62 f AC II Oesophageal cancer,
hypothyroidism
3 I þ D
13 82 f Pneumonia II Dementia e Unﬁt
14 82 f AC II e 1 I þ D
15 70 f AC II HTN, depression e OC
16 80 m AC II TIA 2 RD
17 70 m AC II HTN, CRD, prostate cancer,
PVD, DM
elective OC
18 78 m AC II DM stroke, asthma 2 OC
19 93 f GOO III e e Unﬁt
AC e acute cholecystitis; COPD e chronic obstructive pulmonary disease; CRD e chronic renal disease; DM e diabetes mellitus; GOO e Gastric outlet obstruction;
HTN e hypertension; I þ D e incision and drainage; IHD e ischaemic heart disease; LC e laparoscopic cholecystectomy; OC e open cholecystectomy; PVD e peripheral
vascular disease; RD e radiological drainage; SBO e small bowel obstruction.
R.S. Date et al. / International Journal of Surgery 10 (2012) 63e6864
REVIEW2. Methods
All consecutive cases of gallbladder perforation at a British teaching hospital
from 2004 to 2008 were retrospectively identiﬁed from an electronic patient
database, and the case notes of these patients manually scrutinized. Patients with
perforations due to trauma, iatrogenic causes or gallbladder carcinoma were
excluded. Parameters such as patient demographics, presenting symptoms, co-
morbidities and ﬁtness for surgery (i.e. according to the American Society of Anes-
thesiologists or ASA grading), key investigations, treatment modalities, and eventual
morbidity and mortality were noted.
The literature review involved a comprehensive online search of the MEDLINE,
Embase, Web of Science and Cochrane Library (2011 Issue 4) databases from 1950 to
present, using the search terms ‘gallbladder’, ‘perforation’, ‘cholecystitis’ and ‘Nie-
meier’ in various combinations with the Boolean operators AND and OR. The
abstracts of all full-text English articles were scrutinized. The reference lists of
articles obtained were also searched to identify further relevant citations. The
electronic search was supplemented by a hand search of published abstracts from
meetings of the Association of Surgeons of Great Britain and Ireland (ASGBI), the
Association of Upper Gastrointestinal Surgeons (AUGIS), the Society for Academic
and Research Surgery (SARS), the Swiss Society of Surgery, and the Conference
Proceedings Citation Index on the Web of Science. Finally, the search included the
Current Controlled Trials Register (http://www.controlled-trials.com) and the
Cochrane Database of Controlled Trials.
Case series featuring less than ﬁve patients and those that did not specify the
type of gallbladder perforation according to Niemeier’s classiﬁcationwere excluded.
Parameters which were common to at least half of the extracted studies wereTable 2
Summary data from literature review.




Lennon, 19833 32 e 67 12/32 (37.5%)
Wig, 19849 27 e 50 12/27 (44.4%)
Ong, 199110 6 2/6 (33.3%) 47 1/6 (16.7%)
Menakuru, 200411 31 12/31 (38.7%) 68 9/31 (2.9%)
Derici, 20061 16 10/16 (62.5%) 70 7/16 (44.8%)
Stefanidis, 200612 30 23/30 (76.7%) 60 21/30 (70.0%)
Ergul, 200829 37 20/37 (54.1%) 64 12/37 (32.4%)
Present study 19 10/19 (52.6%) 72 9/19 (47.4%)
Total 198 77/139 e 83/198
Median e 55.4% 62.1 40.6%tabulated for analysis. The outcome data were analysed using SPSS version 15.
Various modes of analysis were used and these are described in Results with the
respective signiﬁcance values. No adjustments were made for multiple testing.
3. Results
3.1. Case series
Over the study duration, 20 patients were treated for gall-
bladder perforation (Table 1). One case history was incomplete and
therefore excluded. The mean age at presentation was 71.5  14.2
(range 37e93) years, with a male:female ratio of 10:9. The majority
of patients had only one signiﬁcant co-morbidity (6/19, 31.6%),
followed by patients with three (4/19, 21.1%), four (4/19, 21.1%) and
zero (3/19, 15.8%) signiﬁcant co-morbidities respectively. Nine
patients had type I perforation, all of which presented as acute
abdominal pain requiring emergency laparotomy. Seven patients
had a preoperative diagnosis of gallbladder perforation based on
radiological imaging. Eight patients underwent open cholecystec-
tomy (OC) and one (Patient 9) underwent cholecystostomy. This
patient had an elective cholecystectomy 2 months later for
a persistent biliary ﬁstula from the drain site. Patient 3 underwente Cholelithiasis Mortality
II III
17/32 (53.1%) 3/32 (9.4%) 27/32 (84.4%) 4/32 (12.5%)
2/27 (7.4%) 13/27 (48.1%) 24/27 (88.9%) 3/27 (11.1%)
5/6 (83.3%) 0/6 (0%) 5/6 (83.3%) 0/6 (0%)
14/31 (4.5%) 8/31 (2.6%) 29/31 (93.5%) 3/31 (9.7%)
7/16 (44.8%) 2/16 (12.5%) e 2/16 (12.5%)
9/30 (30.0%) 0/30 (0%) e e
21/37 (56.8%) 4/37 (10.8%) 33/37 (89.2%) 4/37 (10.8%)
9/19 (47.4%) 1/19 (5.3%) 15/19 (78.9%) 0/19 (0%)
84/198 31/198 133/152 16/168
46.2% 10.1% 86.6% 10.8%
Fig. 2. Computed tomography scan demonstrating perforation of the gallbladder
(black arrows e bile collection; white arrows e gallbladder; asterisk e site of
perforation).
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REVIEWendoscopic retrograde cholangiopancreatography (ERCP) post-
operatively for retained bile duct stones.
Nine patients were found to have type II perforation. Patient 13
was unﬁt for procedural intervention (ASA grade 5) andwas treated
only with appropriate antibiotics. Amongst 4 patients with type II
perforation who underwent OC, 2 were diagnosed intraoperatively
and 2 preoperatively. The remaining 4 patients were elderly and
unwell at presentation (ASA grade 4). They were treated with
computed tomography (CT)-guided transhepatic drainage (Patients
10 and 16) or incision and drainage under local anaesthesia
(Patients 12 and 14). All 4 patients had postoperative contrast
studies via their drainage tubes, two of which showed retained
common bile duct (CBD) calculi (Fig. 1), which were treated
successfully with ERCP.
One patient (Patient 19) presented with gastric outlet obstruc-
tion and was found to have a gallstone penetrating through the
gastric wall on gastroscopy. Subsequent radiological imaging
conﬁrmed the presence of a biliogastric ﬁstula but the patient was
unﬁt for surgery and so was managed conservatively. Overall,
gallbladder perforationwas diagnosed by ultrasonography (USS)(6/
19, 31.6%), CT (7/19, 36.8%) (Fig. 2), MRCP (2/19, 10.5%) (Fig. 3),
gastroscopy (1/19, 5.3%) and intraoperatively (3/19, 15.8%). No
procedure-relatedmorbidity or in-hospital mortality was observed.
There was no signiﬁcant association between patient gender
(p > 0.999; Fisher’s exact test), age (p ¼ 0.186; Student’s t-test) or
the number of co-morbidities (p ¼ 0.306; Linear-by-linear associ-
ation) with perforation type.3.2. Systematic review
The literature search revealed 7 studies that met the review
criteria.1,3,9e13 Including the present series, 198 patients (including
19 patients the present series) with a mean age of 62.1  9.1 (range
47e71) years, and a median male gender proportion of 55.4%
(range 33.3e76.7%), were involved. The most common gallbladder
perforations were type II (median 46.2%, range 7.4e83.3%), fol-
lowed by type I (median 40.6%, range 16.7e70.0%) and type III
(median 10.1%, range 0e48.1%). Perforation was associated withFig. 1. Post-drainage contrast study demonstrating a retained calculus at the lower end
of the common bile duct (arrow).cholelithiasis in 86.6% (median, range 78.9e90.6%) of patients, and
the overall median mortality rate was 10.8% (range 0e12.5%).
There were highly signiﬁcant differences between the propor-
tions of the three perforation types reported by the various studies
(p < 0.001; Pearson ChieSquare test). For example, some studies
reported a high proportion of type III perforation, whilst other
studies included no or few patients with type III perforation.
Interestingly, there was no signiﬁcant association between
mortality and age (p¼ 0.877; Spearman correlation; Table 3). There
was a positive correlation between male gender and mortality at
the 10% signiﬁcance level (p ¼ 0.089); and a weak-positive but
statistically insigniﬁcant correlation between cholelithiasis and
mortality (p ¼ 0.425)(Fig. 5).
Therewas no statistically signiﬁcant correlation between type of
perforation and mortality (Table 4).Fig. 3. Magnetic resonance cholangiopancreatography demonstrating perforation of
the gallbladder (arrowheads e gallbladder; arrow e bile collection; asterisk e site of
perforation).
Table 3




Age (years) average 7 0.073 0.877
Male gender percent (%) 5 0.821 0.089
Cholelithiasis percent (%) 6 0.406 0.425
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The incidences of type I and type II perforationwere equal in the
present series and similar in the systematic review. The main
difference between these two types is that type I perforation is
a clinical diagnosis (e.g. in the form of peritonitis) assisted by radi-
ology, and its treatment is relatively straightforward in the form of
urgent laparotomy (or laparoscopy) and cholecystectomy, or chol-
ecystostomy. In contrast, the decision to treat type II perforations is
far more complex due to the chronic nature of the perforation and
the lack of consensuswithin the published literature about themost
appropriate investigative or treatment modality. In addition, type II
perforations are more likely to occur in older patients with greater
co-morbidities (Table 1), and their questionable ﬁtness for surgery
often limits treatment options and poses challenges to the overall
process of care.
Since the earlier series cited in this review, advances in radio-
logical imaging have allowed for more efﬁcient preoperative
diagnosis of type II perforation, facilitating the timely planning ofFig. 4. Proposed algorithm for the management of type II gallbladder perforation (CBDtreatment. However, the evidence still remains divided regarding
the indications and efﬁcacy of OC over percutaneous drainage (PD)
for type II perforation. In 1985, Felice et al reported mortality rates
following OC and PD as 8.6% and 22% respectively.14 The higher
mortality in the latter cohort was attributed to the fact that PD was
offered only to those patients who were unsuitable or unﬁt for OC.
Huang et al in 2007 reported mortality rates after OC and PD as
50% and 0% respectively but no explanation was offered for the
higher mortality after OC in this study.8 The advancement of
interventional radiological techniques since 1985 has undoubtedly
contributed to the improved mortality rates in patients undergoing
PD for type II perforations. In the present series, radiological
drainage proved to be a valuable alternative to surgery in emergent
situations for patients unﬁt or unwilling for surgery. Combining
elements of current practice with the successful treatment
processes described in recent studies,1,11e13 a simple algorithm for
the management of type II perforation has thus been proposed
(Fig. 4).
In addition to the treatment modalities previously described, it
is important for surgeons to consider a number of novel alterna-
tives in patients who are unsuitable for cholecystectomy. These
include ultrasound-guided transduodenal (or transgastric) gall-
bladder drainage with stenting15 and endoscopic transpapillary
gallbladder stenting.16,17 These techniques have also been
successfully employed when percutaneous transhepatic drainage
or aspiration is contraindicated or anatomically challenging.18
However, although these techniques have demonstrated favour-
able mortality andmorbidity rates, they are currently not offered ine common bile duct; ERCP e endoscopic retrograde cholangiopancreatography).
Fig. 5. Scatterplots demonstrating the frequency-association between age, male
gender and cholelithiasis, with mortality.
Table 4




Perforation type I percent (%) 7 0.236 0.610
Perforation type II percent (%) 7 0.436 0.328
Perforation type III percent (%) 7 0.491 0.263
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REVIEWthe majority of tertiary centres; and high quality evidence in the
form of randomised outcome data are lacking.
4.1. Variations of Niemeier’s classiﬁcation
Niemeier’s original classiﬁcation was conceived purely on the
basis of clinicopathological ﬁndings (i.e. before the advent of
advanced imaging techniques), and its limitations have beencriticised by a number of studies to date. Fletcher and Ravdin
modiﬁed the classiﬁcation in 1951 to highlight more clearly the
differences in mortality between the various clinicodemographic
groups.19 Anderson et al and Ibrarullah et al independently reported
case series of cholecystobiliary ﬁstulae and labelled this phenom-
enon ‘type IV’ perforation.5,6 In contrast, Kochar et al suggested
consolidating the various ﬁstulas (i.e. cholecystobiliary, chol-
ecystocutaneous, cholecystoenteric and cholecystohepatic) into the
category of ‘type III perforation’ to avoid inconsistencies in
reporting.20
Other studies have suggested other perspectives towards the
type III component of the original classiﬁcation. Anderson and
Ibrarullah likened cholecystobiliary ﬁstula to Mirrizzi’s type II
syndrome, which was clearly described in 1948 and subsequently
modiﬁed by McSherry et al, in 1982, into a 2-stage classiﬁcation
based on ERCP and percutaneous transhepatic cholangiography
ﬁndings.21,22
Cholecystoenteric ﬁstula is similarly well described, and may
result in gallstone ileus or Bouveret syndrome (i.e. as in Patient 19).
Unless bowel obstruction ensues, it may be an incidental ﬁnding
during cholecystectomy and may be amenable to laparoscopic or
open surgery.23e27 ‘Cholecystohepatic ﬁstula’ is a misnomer as
ﬁstulas form either between two hollow viscera or between
a hollow viscus and the externa (i.e. the skin). This type of ﬁstula is
in effect a variant of type II perforation occurring in the presence of
a partial or complete intrahepatic gallbladder rupturing ‘intra-
hepatically’, rather than intraperitoneally.
4.2. Limitations
The limitations of the case series include its retrospective nature
and its relatively small patient cohort. The risk stratiﬁcation of
patients could not be performed according to tools such as the
POSSUM scoring system as the required parameters were not
available for all patients in the series.28 However, the study remains
comparable to similar published series in regard to these factors
(Table 2). For the systematic review, a formal meta-analysis was not
possible due to signiﬁcant heterogeneity within the data.
5. Conclusions
In conclusion, a rapid, multimodal diagnostic workup and
accurate identiﬁcation of the type of gallbladder perforation will
aid clinicians in identifying the most effective means of managing
patients with such pathology. For the more complex pathology of
type II perforation, the simple algorithm proposed in this study
aims to guide the investigative pathway and rapid delivery of
treatment in order to minimise subsequent morbidity and
mortality. The signiﬁcant heterogeneity in data (e.g. variation in
incidence of perforation types between studies) suggests a need for
greater clarity in reporting standards to facilitate future outcomes
research and the formulation of new treatment modalities. For the
purpose of clinical clarity, the authors suggest adherence to the
original Neimeier’s classiﬁcation when reporting data on gall-
bladder perforation in future studies, until new evidence forms
a more thorough classiﬁcation system.
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